Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

January 2021 | 50 pages | ID: PD1B22078C4EN
MarketLine

Abstracts

Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

SUMMARY

Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

KEY HIGHLIGHTS

Progenics Pharmaceuticals, Inc. (Progenics or 'the company') is a biopharmaceutical company focused on the development of innovative medicines and other technologies for targeting and treating cancer. Its product portfolio includes therapeutic agents such as AZERDA and PSMA TTC that are designed to precisely target cancer and prostate-specific membrane antigen ('PSMA') targeted imaging agents including PyL used to treat prostate cancer. In addition, it also enters into licensing agreements with the University of Zurich and the Paul Scherrer, The University of Western Ontario, Johns Hopkins University and with Bayers subsidiary for acquiring worldwide sublicensable rights to enhance their product candidates. The company is headquartered in New York, the US.

SCOPE

• Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments
• Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

REASONS TO BUY

• Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Contents

Company Snapshot
Progenics Pharmaceuticals, Inc.: Company Overview
Progenics Pharmaceuticals, Inc.: Overview and Key Facts
Progenics Pharmaceuticals, Inc.: Overview
Progenics Pharmaceuticals, Inc.: Key Facts
Progenics Pharmaceuticals, Inc.: Key Employees
Progenics Pharmaceuticals, Inc.: Key Employee Biographies
Progenics Pharmaceuticals, Inc.: Major Products and Services
Progenics Pharmaceuticals, Inc.: Company History
Progenics Pharmaceuticals, Inc.: Management Statement
Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
Progenics Pharmaceuticals, Inc.: Key Competitors
Progenics Pharmaceuticals, Inc.: Company Analysis
Progenics Pharmaceuticals, Inc.: Business Description
Progenics Pharmaceuticals, Inc.: SWOT Analysis
Progenics Pharmaceuticals, Inc.: SWOT Overview
Progenics Pharmaceuticals, Inc.: Strengths
Progenics Pharmaceuticals, Inc.: Weaknesses
Progenics Pharmaceuticals, Inc.: Opportunities
Progenics Pharmaceuticals, Inc.: Threats
Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Progenics Pharmaceuticals, Inc.: Financial Deals Overview
Progenics Pharmaceuticals, Inc.: Targets and Partners
Progenics Pharmaceuticals, Inc.: Top Deals 2017 - 2021YTD*
Progenics Pharmaceuticals, Inc.: Advisors
Progenics Pharmaceuticals, Inc.: Top Legal Advisors
Progenics Pharmaceuticals, Inc.: Top Financial Advisors
Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions
Progenics Pharmaceuticals, Inc.: Capital Raising
Progenics Pharmaceuticals, Inc.: Partnership
Progenics Pharmaceuticals, Inc.: Private Equity and Ownership
Progenics Pharmaceuticals, Inc.: Recent Developments
Progenics Pharmaceuticals, Inc.: News and Events Summary
Progenics Pharmaceuticals, Inc.: Corporate Governance
Progenics Pharmaceuticals, Inc.: Financial Performance
Progenics Pharmaceuticals, Inc.: Market Developments
Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
Progenics Pharmaceuticals, Inc.: Research & Development
Progenics Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Progenics Pharmaceuticals, Inc.: Key Facts
Table 2: Progenics Pharmaceuticals, Inc.: Key Employees
Table 3: Progenics Pharmaceuticals, Inc.: Company History
Table 4: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Progenics Pharmaceuticals, Inc.: Key Competitors
Table 6: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Table 8: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Progenics Pharmaceuticals, Inc.: Targets and Partners
Table 10: Progenics Pharmaceuticals, Inc.: Top Deals 2017 - 2021YTD*
Table 11: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 - YTD*2021)
Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 - YTD*2021)
Table 15: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 - YTD*2021)
Table 16: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 - YTD*2021)
Table 17: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 - YTD*2021)
Table 18: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 - YTD*2021)
Table 19: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 - YTD*2021)
Table 20: Progenics Pharmaceuticals, Inc.: News and Events Summary
Table 21: Progenics Pharmaceuticals, Inc.: Corporate Governance
Table 22: Progenics Pharmaceuticals, Inc.: Financial Performance
Table 23: Progenics Pharmaceuticals, Inc.: Market Developments
Table 24: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 25: Progenics Pharmaceuticals, Inc.: Research & Development
Table 26: Progenics Pharmaceuticals, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Figure 3: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 - YTD*2021)
Figure 5: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 - YTD*2021)
Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 - YTD*2021)
Figure 7: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 - YTD*2021)
Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 - YTD*2021)
Figure 9: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 - YTD*2021)
Figure 10: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 - YTD*2021)